Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial
PaperCitations, authors & open-access status
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 365 citations, 2021 year and bronze oa status.
365
Citations
2021
Year
bronze
OA Status